| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $3.2M | — | -54.8% |
| SG&A Expense | $4.5M | — | -11.8% |
| Operating Income | -$7.7M | — | +36.8% |
| Income Tax | $0 | — | — |
| Net Income | -$7.6M | — | +31.0% |
| EPS (Basic) | -$0.54 | — | +40.0% |
| EPS (Diluted) | -$0.54 | — | +40.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $50.8M | +5.1% | -22.5% |
| Current Assets | $57.2M | +3.9% | -16.7% |
| Total Assets | $63.7M | +3.1% | -19.5% |
| Current Liabilities | $10.7M | -6.0% | -26.8% |
| Total Liabilities | $17.4M | -12.1% | -79.1% |
| Stockholders' Equity | $46.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.3M | — | +49.2% |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $8.8M | — | — |
| +1253.8% |